We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| BridgeBio Pharma Inc | NASDAQ:BBIO | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.72 | 2.96% | 25.05 | 1,049,219 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 24.61 | 25.31 | 24.99 | 24.32 | 24.48 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 9.3M | -643.2M | -3.6581 | -6.80 | 4.38B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 00:43:23 | 1 | 24.95 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 05/12/2023 | 13:52 | DJN | BridgeBio Seeks FDA Approval of Acoramidis in Transthyretin Amyloid.. |
BridgeBio Pharma (BBIO) Share Charts1 Year BridgeBio Pharma Chart |
|
1 Month BridgeBio Pharma Chart |
Intraday BridgeBio Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
